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in developing countries could be 
partly due to differences in lumi-
nal bacteria that colonize infants 
early in life. Transmissibility of IBD 
in humans has not been observed, 
perhaps because humans are more 
selective than mice in what they 
consume, and antibiotics have had 
mixed success in the treatment of 
IBD. Nevertheless, future metage-
nomic analyses, perhaps combined 
with therapeutic manipulations, may 
allow us to gain insights into the 
complex interactions in the intes-
tinal microenvironment in human 
disease.
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Retroviral capsids are composed of hexagonal arrays of the viral CA protein. In this issue 
of Cell, Ganser-Pornillos et al. (2007) provide a molecular model of the hexagonal HIV-1 CA 
lattice obtained from a new electron cryomicroscopic reconstruction. This study reveals 
the three principal stabilizing interfaces in the capsid lattice and explains how two different 
classes of inhibitors can block capsid assembly.Like all retroviruses, HIV-1 is com-
posed of a series of protein shells that 
organize the virion and help to facili-
tate the early stages of viral replica-
tion. The virion exterior comprises a 
lipid bilayer that is studded with trans-
membrane envelope protein spikes 
and coated on its internal surface by a 
matrix shell composed of the viral MA 
protein. Inside the matrix is a conical 
capsid composed of CA protein sub-
units that surround the viral nucleo-
capsid—a ribonucleoprotein complex 
composed of the RNA genome, NC 
protein, and viral enzymes. The HIV 
capsid has become a major focus of 
research owing to its intriguing coni-
cal morphology, its potential as a drug 
target, its critical functions at early 
stages of viral replication, and its inter-
actions with innate immunity factors.Studies of the HIV capsid have 
used a complementary array of dif-
ferent structural methods, each with 
its own strengths and limitations. 
Direct imaging of HIV CA protein 
assemblies using electron micros-
copy (EM) revealed that capsids 
belong to a family of closed geomet-
ric objects called fullerene cones that 
are composed primarily of hexagonal 
arrays of hexameric CA protein rings, 
with an additional twelve pentameric 
rings that allow the cones to close 
at both ends (Ganser et al., 1999; Li 
et al., 2000). These studies estab-
lished the global capsid architecture 
but lacked the resolution necessary 
to visualize details of subunit pack-
ing interactions. In contrast, NMR 
and X-ray crystallography have pro-
duced high-resolution structures of Cell 131,the two domains of CA, the N-ter-
minal domain (NTD, helices 1–7) and 
the C-terminal domain (CTD, helices 
8–11), but have failed to provide a 
comprehensive picture of the subunit 
interactions in the hexagonal CA lat-
tice (Gamble et al., 1997; Gitti et al., 
1996). Fortunately, a new study in this 
issue by Ganser-Pornillos et al. (2007) 
bridges this gap in understanding by 
revealing the structure of the mature 
HIV CA protein in its native hexagonal 
packing environment.
Ganser-Pornillos and colleagues 
(2007) used electron cryomicroscopy 
(cryo-EM) and image reconstruction 
to visualize double-layered 2D crys-
tals of hexamers formed by a mutant 
HIV-1 CA protein with particularly 
favorable assembly properties. The 
reconstruction confirms and extends  October 5, 2007 ©2007 Elsevier Inc. 17
figure 1. Hexagonal Lattice of the HIV-1 cA Protein
(A) Overview of the hexagonal CA lattice, as viewed from the capsid exterior. Seven CA hexamers are shown, and the subunits are colored individu-
ally in two of the hexamers. Note that the CA N-terminal domains (NTD, bright shades) define the capsid exterior whereas the C-terminal domains 
(CTD, light shades) define the capsid interior. The CTD dimer (black dyad) and NTD-CTD (white asterisk) interfaces are highlighted here and are 
shown in expanded views in (B) and (C), respectively.
(B) CA dimer viewed parallel (upper) and perpendicular (lower) to the two-fold axis of the CTD-CTD interface that connects adjacent hexamers.
(C) NTD-CTD interface formed between adjacent subunits in each CA hexamer. Structures of bound CAI (yellow) (Ternois et al., 2005) and CAP-1 
(green) (Kelly et al., 2007) illustrate how these inhibitors could disrupt interface formation and thereby block capsid assembly.
Figure images created by Brian Kelly using coordinates from Ganser-Pornillos et al. (2007) and the program PyMOL.several structural features that had 
been widely assumed but not fully 
verified. In particular, the structure 
demonstrates that CA NTD forms 
hexameric rings that are stabilized 
primarily by intermolecular interac-
tions between helices 1–3 (Figure 
1A). This arrangement was seen pre-
viously in an X-ray crystal structure of 
the CA NTD from the distantly related 
murine leukemia virus (Mortuza et al., 
2004). Therefore, all retroviral capsids 
appear to be composed of similar hex-
americ building blocks, even though 
their CA proteins have diverged con-
siderably in primary sequence and 
their capsids can adopt different 
shapes (spheres, rods, or cones). The 
new structure also shows that the CA 
CTD forms homodimeric interactions 
that connect neighboring hexamers 
through an interface that was previ-
ously observed in an HIV-1 CA CTD 
crystal structure (Figure 1B), although 
this interaction may adjust slightly to 
accommodate the constraints of the 
hexameric lattice (Ganser-Pornillos et 
al., 2007).
Most importantly, the new struc-
ture provides the first picture of the 
elusive third interface that is required 
to form a stable hexagonal CA lattice. 
This interface is created by the inter-18 Cell 131, October 5, 2007 ©2007 Elsemolecular packing of one CA CTD 
against the NTD of an adjacent sub-
unit within the hexamer, with the ter-
mini of NTD helices 4 and 7 packing 
into a groove created by CTD helices 
8, 9, and 11. This nicely explains pre-
vious genetic and biochemical data 
that indicated that the CA NTD and 
CTD interact within the viral capsid. 
For example, Craven and colleagues 
showed that a mutation within helix 
9 of the Rous sarcoma viral CA CTD 
that inhibited capsid assembly could 
be suppressed by second site muta-
tion within NTD helix 4 (Bowzard et 
al., 2001). Similarly, Prevelige and 
colleagues showed that HIV-1 capsid 
assembly brings the CA NTD and CTD 
close enough to allow crosslinking of 
lysine residues in helices 4 and 9, and 
they mapped interacting patches on 
the two domains using deuterium 
exchange protection (Lanman et 
al., 2003). The excellent agreement 
between genetic, biochemical, and 
structural studies leaves little doubt 
as to the biological authenticity of the 
new structure.
The newly visualized CA NTD-CTD 
interaction also explains the mecha-
nism of action of two capsid assembly 
inhibitors that have recently been char-
acterized structurally; a helical peptide vier Inc.inhibitor (CAI) that binds between CA 
CTD helices 8 and 11 (Ternois et al., 
2005), and a small molecule inhibitor 
(CAP-1) that binds in a pocket formed 
at the junction between helices 1, 2, 4 
and 7 in the CA NTD (Kelly et al., 2007). 
As illustrated in Figure 1C, these inhib-
itors bind within or adjacent to the 
third interface and probably disrupt 
this interaction thereby inhibiting cap-
sid assembly. The expanding problem 
of HIV drug resistance continues to 
fuel the search for new viral inhibitors, 
and the functional importance of the 
viral capsid makes CA an attractive 
new drug target. Several major chal-
lenges must be overcome in devel-
oping CA inhibitors, however, includ-
ing the presence of thousands of CA 
molecules within each virion and the 
need to inhibit protein-protein interac-
tions, which typically do not possess 
the deep binding grooves of enzyme 
active sites. Nevertheless, these chal-
lenges may be mitigated by the highly 
cooperative nature of capsid assem-
bly, which likely restricts the range of 
interface stabilities that can support 
both capsid assembly and disas-
sembly, and by the possibility that 
inhibiting even a small subset of the 
CA interfaces may “poison” capsid 
lattice growth. The development and 
characterization of even better small 
molecule inhibitors of HIV-1 capsid 
assembly will undoubtedly be aided 
by our improved understanding of the 
different protein-protein interactions 
within the CA lattice.
Despite this progress, a full under-
standing of HIV-1 capsid structure 
and function will require further 
advances, including: (1) learning how 
the flat hexagonal CA lattice adjusts 
to form the gradually curving body of 
the conical capsid; (2) visualizing the 
capsid lattice structure at a resolution 
sufficient to define sidechain interac-
tions and guide inhibitor development; 
(3) characterizing the pentameric CA 
assemblies that are required to close 
the conical capsid; (4) establishing 
how sequential proteolytic process-The organization of signaling mol-
ecules into macromolecular assem-
blies is essential for achieving speci-
ficity in signaling, as it is common 
for proteins functioning in one signal 
transduction cascade to be employed 
by others. Signaling complexes are 
also crucial to cascades that operate 
over very short time scales, such as 
during phototransduction in the fruit 
fly Drosophila. Without these mac-
romolecular assemblies, the speed 
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which has important consequeing of the Gag precursor protein 
drives capsid assembly during viral 
maturation; and (5) most importantly, 
learning the detailed fates of capsids 
as they enter the cytoplasm, inter-
act with host factors, and support 
the early stages of viral replication. 
These outstanding issues ensure that 
capsids will remain at the forefront of 
retrovirology for some time to come.
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this concept needs to be reevalu-
ated in light of a study reported in 
this issue by Mishra and colleagues. 
They demonstrate that one of the 
PDZ domains in INAD, a molecular 
scaffold in Drosophila photoreceptor 
cells, undergoes a light-dependent 
conformational change. The dynamic 
structural transformation disrupts 
the surface groove important for 
PDZ/target protein interactions and 
has important physiological effects 
on the light response.
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